Latest Breaking News On - Reference listed drug - Page 1 : vimarsana.com

Stocks in news: Apollo Tyres, Paytm, BHEL, Sun Pharma, Grasim, Ircon and PI Industries

Sun Pharma, Power Grid, Grasim, Max Healthcare, India Bank, Nykaa, Petronet LNG, Metro Brands, Gland Pharma and Paytm are among the companies that will announced Q4 results later today.

Indoco Remedies shares gain on final USFDA approval for Pregabalin capsules

The share touched a 52-week high of Rs 416.95 and a 52-week low of Rs 308.80 on January 1, 2024, and October 26, 2023, respectively.

Strides receives USFDA approval for Sucralfate oral suspension; stocks move up

Strides Pharma gains 0.76% as USFDA approves Sucralfate Oral Suspension, expanding product portfolio and market reach.

Strides Pharma gets USFDA approval for its generic formulation to treat GERD

USFDA Grants Approval To Strides Pharma For Generic GERD Treatment Formulation

Moreover, Strides Pharma’s ambitious plans to launch approximately 60 new products in the US over the next three years further underscore its commitment to portfolio diversification and expansion. This forward-looking approach aligns with the company’s overarching objective of bolstering its market presence and addressing evolving healthcare needs. - Newsx

Stock Radar: BHEL, PI Industries, Metrpolis, Sheela Form, PNC Infratech, Biocon in focus on Wednesday

Grasim Industries, Sun Pharma, Power Grid Corporation, Paytm, Nykaa, Ashoka Buildcon, Dhanlaxmi Bank, GE Power India, Gland Pharma, GMM Pfaudler, HEG, Jubilant FoodWorks, New India Assurance Company, and Unichem Laboratories will announce their March quarter earnings on May 22.

United States - Patent - Ophthalmic, Parenteral, & Otic Drug Development: Does FDA's Draft Guidance Provide A Vehicle To Avoid Patent Problems?

In April 2022, FDA released a proposed draft guidance (FDA Dock. No. 2022-D-0108) involving pH adjusters in drug development relating to ophthalmic, parenteral, or otic drug products.

Strides Pharma gets USFDA nod for its drug to treat elevated phosphorous levels

Strides Pharma Global receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg

Strides Pharma Science Singapore arm gets USFDA nod for Major Depressive Disorder drug Fluoxetine

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug Prozac Tablets of Eli Lilly.